Home   l   Log in   l     
HOME
ABOUT US
Lilly Asia Ventures, founded in 2008, is dedicated to venture capital investments in the life sciences and healthcare sectors in Asia, particularly in China. Its investors include
Eli Lilly & Co., a Fortune 500 company and one of the most globalized and innovative pharmaceutical companies in the world. As a leading biomedical venture fund in China, Lilly Asia Ventures provides wise capital, industry expertise, and global resources to its portfolio companies to accelerate their growth.
PORTFOLIO
 Room 2909, 3 Corporate Avenue, No.168 Hubin Road  
 +86 21 2316 9588  
copyright © 2012-2015 Lilly Asia Ventures all rights reserved.